KAREN WILSON: Open Payments
NPI 1134499676 · HAWTHORNE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 32 payments from 7 companies in 2025. Trend: 2023 $937 · 2024 $744 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $167 |
| Teva Pharmaceuticals USA, Inc. | 7 | $159 |
| Lundbeck LLC | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: REXULTI, VRAYLAR, AUSTEDO XR, COBENFY, Auvelity, UZEDY, CAPLYTA.
Industry payments across NY — which companies pay providers there.
